Particle.news

Northwestern Medicine Launches Centralized Transplant Institute

The move aims to speed clinical trials that could reduce patients' lifelong need for anti-rejection drugs.

Overview

  • The new institute folds four existing Northwestern transplant programs into one hub backed by about $26 million in philanthropic funding, roughly 300 staff and a program that performed 691 transplants last year.
  • Leadership says the institute will prioritize clinical trials testing whether transplant recipients can reduce or stop long-term anti-rejection medication and will more actively discuss trial options with patients.
  • The institute covers all-organ and pediatric transplants and includes large living-donor services, illustrated by a recent daughter-to-father kidney donation at Northwestern.
  • Northwestern cites demand in the region where OPTN data show more than 4,700 people in Illinois waiting for organs, mostly kidneys, and promotes its high volumes including a program milestone of 3,000 liver transplants.
  • Officials expect the consolidation to widen patient access to research and to accelerate technology-driven work such as AI donor matching, robotic surgery and regenerative approaches that could shorten wait times and reduce long-term treatment burdens for recipients.